연구동향 분석

ORIGINAL ARTICLE : The Effect of Imiquimod on Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Malignant Melanoma Cell Invasion

( Jin Young Jung ) ( Hyun Sook Kim ) ( Mi Ryung Roh ) ( Hyo Jin Roh ) ( Sang Yoon Lee ) ( Kee Yang Chung ) 2014년

논문상세정보
인용/피인용
' ORIGINAL ARTICLE : The Effect of Imiquimod on Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Malignant Melanoma Cell Invasion' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • imiquimod
  • invasion
  • matrix metalloproteinase
  • melanoma
  • tissueinhibitorofmetalloproteinase
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
318 0

0.0%

' ORIGINAL ARTICLE : The Effect of Imiquimod on Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Malignant Melanoma Cell Invasion' 의 참고문헌

  • Up-regulation of vascular endothelial growth factor by membrane-type 1matrix metalloproteinase stimulates human glioma xenograft growth and angiogenesis
    Deryugina EI Cancer Res 62 : 580 ~ 588 [2002]
  • Tumor-selective induction of apoptosis and the small-molecule immune response modifier imiquimod
    Schön M J Natl Cancer Inst 95 : 1138 ~ 1149 [2003]
  • Treatment of lentigo maligna with topical imiquimod
    Naylor MF Br J Dermatol 149 (Suppl 66) : 66 ~ 70 [2003]
  • Treatment of lentigo maligna with imiquimod before staged excision
    Cotter MA Dermatol Surg 34 : 147 ~ 151 [2008]
  • Treatment of lentigo maligna (melanoma in situ) with the immune response modifier imiquimod
    Wolf IH Arch Dermatol 141 : 510 ~ 514 [2005]
  • Tissue inhibitors of metalloproteinases: structure, regulation and biological functions
    Gomez DE Eur J Cell Biol 74 : 111 ~ 122 [1997]
  • Tissue inhibitors of metalloproteinases: evolution, structure and function
    Brew K Biochim Biophys Acta 1477 : 267 ~ 283 [2000]
  • Tissue inhibitors of metalloproteinases (TIMP) in invasion and proliferation
    Henriet P APMIS 107 : 111 ~ 119 [1999]
  • The use of Toll-like receptor-7 agonist in the treatment of basal cell carcinoma : an overview
    Stockfleth E Br J Dermatol 149 (Suppl 66) : 53 ~ 56 [2003]
  • The tumor microenvironment: regulation by MMP-independent effects of tissue inhibitor of metalloproteinases-2
    Stetler-Stevenson WG Cancer Metastasis Rev 27 : 57 ~ 66 [2008]
  • The TIMP2 membrane type 1 metalloproteinase “receptor” regulates the concentration and efficient activation of progelatinase A. A kinetic study
    Butler GS J Biol Chem 273 : 871 ~ 880 [1998]
  • The 92-kDa gelatinase B is expressed by advanced stage melanoma cells: suppression by somatic cell hybridization with early stage melanoma cells
    MacDougall JR Cancer Res 55 : 4174 ~ 4181 [1995]
  • TIMP-2: an endogenous inhibitor of angiogenesis
    Stetler-Stevenson WG Trends Mol Med 11 : 97 ~ 103 [2005]
  • Suppression of the tumorigenic and metastatic abilities of murine B16-F10 melanoma cells in vivo by the overexpression of the tissue inhibitor of the metalloproteinases-1
    Khokha R J Natl Cancer Inst 86 : 299 ~ 304 [1994]
  • Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway
    Hemmi H Nat Immunol 3 : 196 ~ 200 [2002]
  • Role of matrix metalloproteinases in melanoma cell invasion
    Hofmann UB Biochimie 87 : 307 ~ 314 [2005]
  • Regulation of cell invasion and morphogenesis in a three-dimensional type I collagen matrix by membrane-type matrix metalloproteinases 1, 2, and 3
    Hotary K J Cell Biol 149 : 1309 ~ 1323 [2000]
  • Recurrence of lentigo maligna and development of invasive melanoma after treatment of lentigo maligna with imiquimod
    Woodmansee CS Dermatol Surg 35 : 1286 ~ 1289 [2009]
  • Recurrence of lentigo maligna after initial complete response to treatment with 5% imiquimod cream
    van Meurs T Dermatol Surg 33 : 623 ~ 626 [2007]
  • Prognostic value of MMP-2 immunoreactive protein (72 kD type IV collagenase) in primary skin melanoma
    Väisänen A J Pathol 186 : 51 ~ 58 [1998]
  • Metastatic potential correlates with enzymatic degradation of basement membrane collagen
    Liotta LA Nature 284 : 67 ~ 68 [1980]
  • Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancer
    Pyke C Am J Pathol 142 : 359 ~ 365 [1993]
  • Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases
    d'Ortho MP Eur J Biochem 250 : 751 ~ 757 [1997]
  • Membrane type-1 matrix metalloproteinase promotes human melanoma invasion and growth
    Iida J J Invest Dermatol 122 : 167 ~ 176 [2004]
  • Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease
    Strongin AY J Biol Chem 270 : 5331 ~ 5338 [1995]
  • Matrix metalloproteinases:regulators of the tumor microenvironment
    Kessenbrock K Cell 141 : 52 ~ 67 [2010]
  • Matrix metalloproteinases: a tail of a frog that became a prince
    Brinckerhoff CE Nat Rev Mol Cell Biol 3 : 207 ~ 214 [2002]
  • Matrix metalloproteinases in human melanoma
    Hofmann UB J Invest Dermatol 115 : 337 ~ 344 [2000]
  • Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry
    Visse R Circ Res 92 : 827 ~ 839 [2003]
  • Matrix metalloproteinases and tissue inhibitor of metalloproteinases are essential for the inflammatory response in cancer cells
    Sun J J Signal Transduct 2010 : 985132 ~ [2010]
  • Matrix metalloproteinase-2 (72 kD type IV collagenase)expression occurs in the early stage of human melanocytic tumour progression and may have prognostic value
    Väisänen A J Pathol 180 : 283 ~ 289 [1996]
  • Integrin adhesion receptors in tumor metastasis
    Felding-Habermann B Clin Exp Metastasis 20 : 203 ~ 213 [2003]
  • In vivo and in situ modulation of the expression of genes involved in metastasis and angiogenesis in a patient treated with topical imiquimod for melanoma skin metastases
    Hesling C Br J Dermatol 150 : 761 ~ 767 [2004]
  • In vitro susceptibility to the pro-apoptotic effects of TIMP-3 gene delivery translates to greater in vivo efficacy versus gene delivery for TIMPs-1 or -2
    Finan KM Lung Cancer 53 : 273 ~ 284 [2006]
  • Homophilic complex formation of MT1-MMP facilitates pro-MMP-2 activation on the cell surface and promotes tumor cell invasion
    Itoh Y EMBO J 20 : 4782 ~ 4793 [2001]
  • Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis
    Stetler-Stevenson WG FASEB J 7 : 1434 ~ 1441 [1993]
  • Expression of matrix metalloproteinases in the microenvironment of spontaneous and experimental melanoma metastases reflects the requirements for tumor formation
    Hofmann UB Cancer Res 63 : 8221 ~ 8225 [2003]
  • Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary
    Sakata K Int J Oncol 17 : 673 ~ 681 [2000]
  • Expression of gelatinase B and the extracellular matrix metalloproteinase inducer EMMPRIN in benign and malignant pigment cell lesions of the skin
    van den Oord JJ Am J Pathol 151 : 665 ~ 670 [1997]
  • Expression and role of matrix metalloproteinases MMP-2 and MMP-9 in human spinal column tumors
    Gokaslan ZL Clin Exp Metastasis 16 : 721 ~ 728 [1998]
  • Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1matrix metalloproteinase (MT1-MMP) correlate with melanoma progression
    Hofmann UB J Pathol 191 : 245 ~ 256 [2000]
  • Effect of tissue inhibitor of the matrix metalloproteinases-2 expression on the growth and spontaneous metastasis of a human melanoma cell line
    Montgomery AM Cancer Res 54 : 5467 ~ 5473 [1994]
  • Death receptor-independent apoptosis in malignant melanoma induced by the small-molecule immune response modifier imiquimod
    Schön MP J Invest Dermatol 122 : 1266 ~ 1276 [2004]
  • Biochemical interactions of tumor cells with the basement membrane
    Liotta LA Annu Rev Biochem 55 : 1037 ~ 1057 [1986]